New USTR Tariffs on Medical Gloves: Securing America’s Medical Supply Chain

The U.S. Trade Representative (USTR) has announced substantial tariff increases on medical gloves imported from China, reflecting a broader effort to strengthen America’s domestic medical manufacturing base. These new tariffs are a critical component of the government’s strategy to reduce dependence on foreign suppliers for essential medical supplies and to encourage investment in U.S. production.

Strengthening the U.S. Medical Industrial Base

Starting in 2025, the import duty on medical gloves will increase to 50%; by 2026, this rate will rise to 100%. These measures are intended to safeguard recent U.S. investments in domestic glove production, ensuring the nation is better prepared for future healthcare crises like the COVID-19 pandemic. The tariffs are designed to encourage a shift away from reliance on Chinese imports, which currently dominate the market, and create a more resilient, diversified, and secure domestic supply chain for medical gloves​(Section 301 Modification…).

Circumvention Tactics: Beating the Deadline

As with any significant trade measure, foreign manufacturers must seek ways to evade these new tariffs. A likely short-term strategy is to expedite shipments of gloves to the U.S. before the new tariffs take effect. We anticipate a surge in container shipments from China in the months of September, October, and November 2024 as companies try to avoid the 50% tariff hike by ensuring their goods reach U.S. ports before Christmas. This rush to beat the deadline is expected to increase container volumes, requiring U.S. Customs and Border Protection (CBP) vigilance to ensure that these shipments comply with trade regulations.

Exploiting ASEAN Trade Loopholes

More troubling is the long-term strategy Chinese manufacturers may adopt to circumvent these tariffs. Starting in December 2024, Chinese glove producers are expected to shift production capacity to manufacturers in ASEAN (Association of Southeast Asian Nations) countries, using these countries as transit points to export gloves to the U.S. By altering the country of origin and masking the true origin of the goods, these producers hope to avoid the 50% tariff on Chinese products.

This transshipment tactic is familiar and seriously threatens U.S. efforts to rebuild its medical-industrial base. ASEAN traders will likely take advantage of this opportunity to export Chinese-made gloves and other personal protective equipment (PPE) as “Made in ASEAN” products, thus evading the steep import duties. This practice undermines the intent of USTR’s tariff policy, which aims to foster a robust domestic supply chain while reducing dependence on foreign, mainly Chinese, manufacturing.

AMMA’s Call to Action

At the American Medical Manufacturers Association (AMMA), addressing these circumvention tactics head-on is crucial. We urge U.S. policymakers and the CBP to closely monitor these developments and take strong enforcement measures to prevent transshipment fraud. We must close any loopholes that allow Chinese manufacturers to sidestep the tariffs, as doing so would weaken U.S. manufacturing and prolong our dependence on foreign PPE.

The USTR’s decision to impose significant tariffs on medical gloves is a step in the right direction, but its success will depend on robust enforcement. The AMMA stands ready to work with government agencies to ensure that tariff policies are upheld and that U.S. manufacturers have a level playing field to compete and grow.

Conclusion

The USTR’s new tariffs on Chinese medical gloves represent a vital opportunity to strengthen the U.S. medical-industrial base. However, without diligent enforcement, circumvention tactics from Chinese manufacturers could render these tariffs ineffective. AMMA will continue to advocate for strong policies that support U.S. manufacturing and supply chain security. Together, we can reduce reliance on foreign manufacturers and ensure the U.S. is prepared for future healthcare challenges.

Dan Izhaky · September 18, 2024 · Originally published on Medium · All writing · Next: Pandemic Preparedness: A Crucial Step Forward